These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12937060)

  • 1. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
    Cleary AG; Brown B; Minards J; Sills J; Bolton-Maggs P
    Arch Dis Child Fetal Neonatal Ed; 2003 Sep; 88(5):F444; author reply F445. PubMed ID: 12937060
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.
    Alpay F
    Acta Paediatr; 2000 Mar; 89(3):371-2. PubMed ID: 10772295
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in neonatal rhesus hemolytic disease.
    Greenough A
    Indian Pediatr; 2008 Aug; 45(8):649-50. PubMed ID: 18723906
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of Kawasaki disease.
    Sagraves R
    J Pediatr Health Care; 1993; 7(6):278-82. PubMed ID: 8106928
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia.
    Marković-Sovtić G; Janković B; Rakonjac Z; Martić J; Pejić K
    Vojnosanit Pregl; 2013 Nov; 70(11):1029-33. PubMed ID: 24397198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International guidelines regarding the role of intravenous immunoglobulin in the management of RhD- and ABO-mediated haemolytic disease of the newborn-reconsidering the recommendations.
    Hansen TWR; Akkök CA; Watchko JF
    Br J Haematol; 2022 Nov; 199(3):452-453. PubMed ID: 35993219
    [No Abstract]   [Full Text] [Related]  

  • 8. Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage.
    Singh S; Kumar L
    Indian Pediatr; 1996 Aug; 33(8):689-92. PubMed ID: 8979554
    [No Abstract]   [Full Text] [Related]  

  • 9. Kawasaki disease in a preterm neonate: Case report and cytokine profile.
    Okazaki K; Matsui K; Takahashi N; Miura M; Kondo M
    Pediatr Int; 2018 Nov; 60(11):1037-1039. PubMed ID: 30378211
    [No Abstract]   [Full Text] [Related]  

  • 10. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
    Keir AK; Dunn M; Callum J
    J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
    Louis D; More K; Oberoi S; Shah PS
    Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F325-31. PubMed ID: 24514437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for intravenous immunoglobulin therapy of Kawasaki disease.
    Shulman ST
    Pediatr Infect Dis J; 1992 Nov; 11(11):985-6. PubMed ID: 1454455
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of intravenous immunoglobulins in pediatric diseases.
    Ramasubramanian KV; Kumar A; Kabra SK; Seth V
    Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
    [No Abstract]   [Full Text] [Related]  

  • 14. The Clinical Utility of Intravenous Immunoglobulin and When to Involve Our Consultants.
    Hageman JR
    Pediatr Ann; 2017 Jan; 46(1):e1. PubMed ID: 28079909
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1992 Jan; 146(2):121-4. PubMed ID: 1735037
    [No Abstract]   [Full Text] [Related]  

  • 16. The mechanism of efficacy of intravenous immunoglobulin in Kawasaki disease.
    Kaneka K; Savage CO; Pottinger BE; Shah V; Pearson JD; Dillon MJ
    Pediatr Infect Dis J; 1994 Nov; 13(11):1022-3. PubMed ID: 7845731
    [No Abstract]   [Full Text] [Related]  

  • 17. Kawasaki disease in Calcutta.
    Paul DK; Gupta A; Lahiri M
    Indian Pediatr; 2000 Nov; 37(11):1264-5. PubMed ID: 11086312
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
    Gottstein R; Cooke RW
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in immunoglobulin preparations and outcome of Kawasaki disease.
    Yavuz H; Ozel A
    J Pediatr; 1996 May; 128(5 Pt 1):719-20. PubMed ID: 8627453
    [No Abstract]   [Full Text] [Related]  

  • 20. Uses of intravenous globulin to prevent or treat infections.
    Fischer GW
    Adv Pediatr Infect Dis; 1992; 7():85-108. PubMed ID: 1616688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.